Sarah Rider PMHNP Department of Psychiatry University of Colorado Anschutz Medical Campus Center for Dependency Addiction and Rehabilitation A Division of University of Colorado Hospital ID: 931918
Download Presentation The PPT/PDF document "WHAT’S IN A NAME? STIGMA, SUBSTANCE US..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
WHAT’S IN A NAME?
STIGMA, SUBSTANCE USE, AND LANGUAGE
Sarah Rider, PMHNPDepartment of Psychiatry University of Colorado Anschutz Medical Campus
Center for Dependency, Addiction and RehabilitationA Division of University of Colorado Hospital
Slide2Substance use and the implications of stigma
Terminology
Documentation
QuestionsOVERVIEW
Slide3Slide4This stigma associated with drug use--the belief that bad kids use, good kids don't, and those with full-blown addiction are weak, dissolute, and pathetic--has contributed to the escalation of use and has hampered treatment more than any single other factor.
~David Sheff
Slide5Slide6LABELING
ASSOCIATING NEGATIVE ATTRIBUTES
SEPARATING “US” FROM “THEM”
DISCRIMINATION STIGMA LINK-PHELAN MODEL
Slide7STIGMA AND SUBSTANCE USE
Factors that Increase Blame and Judgement
Cause (it’s their fault)
Control (they could stop if they wanted)Treatability (poor prognosis)
Slide8STIGMA Domains
Communities: stereotyping, fear, rejection
Systems: health, legal, economicPersonal: shame, worth, isolationMedications: misconceptions, restrictions, disparities
Slide9Slide10TERMINOLOGY
Addiction is a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual’s life experiences. People with addiction use substances or engage in behaviors that become compulsive and often continue despite harmful consequences.
Prevention efforts and treatment approaches for addiction are generally as successful as those for other chronic diseases.
(American Society of Addiction Medicine, 2019)
Slide11Slide12GENERALGUIDELINES
Chronic Health Condition: medical terminology for medical settings
Treatable: instills confidence Person-first: individual before the condition/disease/behavior
Strengths-based: builds on resilience, empowersUse language that is consistent with how the person identifies: ask!
Slide13Slide14Chronic Health Condition:
-Patient describes drinking 1-2 pints of vodka daily for 3-4 years. She reports last drink as yesterday, 1/1/1, at approximately 2300. Patient states she feels “shaky” and anxious this evening. She throws up when she eats and thinks there was some bright red blood in vomit.
Treatable: -”I don't understand everything you are going through, but maybe together we can find something that could work for you. “Person-first: -Patient is diagnosed with opioid use disorder, severe, in sustained remission x 15 years.
Strengths-based: -”It's clear you're really trying to change your cannabis use.” -”I can see that you are a very resourceful person.”
Slide15Instead of…
Use…
Because…Abuse
DependanceHabitRecreationalSubstance UseSubstance Use DisorderUnhealthy/Hazardous UseMisuse/Not using as prescribed (for prescription medications)Reflects current diagnostic terminologyIncreases consistency in medical documentationDrug of choicePatient reports using Patient states they useRecent substance use includesHistory of *** use
Considers the biomedical and psychosocial understanding of substance use
Addict
Alcoholic
Injection user/Injection drug use (IDU)
Substance abuser
Alcoholic
Former addict
Reformed addict
Has a substance disorder
Person who uses substances
Person who is using
Person who injects drugs (PWID)
Person in recovery
Substance use in remission
Sustained abstinence
Terms like alcohol abuse, drug abuse, substance abuse all spring from religious and moral conceptions of SUDs that assign blame to the individual.
The person has a problem rather than is the problem.
Medication Assisted Treatment (MAT)
Replacement therapy
Substitution therapy
Medications for substance use treatment
Pharmacotherapy
Opioid Agonist Treatment (OAT)
Medication for Opioid Use Disorder (MOUD)
Medications for Addiction Treatment (MAT)
Acknowledgment that pharmacotherapy is a first-line treatment that is central to a patient’s treatment plan.
Taking a medications for opioid use disorder is not equivalent to using opioids in the context of a use disorder.
Consistent with general medical terminology
Clean
Dirty
Negative/Positive result
Expected/Unexpected result
Clinically accurate, non-stigmatizing, non-punitive
Model with your own language when treating patients who might use stigmatizing slang
Relapse
Recurrence of use
Returned to use
Began using
Experienced a recurrence of symptoms
Consistent with general medical terminology (i.e. recurrence of symptoms)
In no other chronic medical condition is a return to being symptomatic described a “relapsing”
Needle Exchange
Clean/Dirty (e.g. syringes and other supplies for using substances)
Syringe service program (SSP)
Harm Reduction Services
Sterile/Used equipment/supplies/syringes
Captures a full-range of services that many programs provide
AA
12-step
Self-help
Mutual aid groups
Peer support groups
Peer recovery services
Inclusive
Acknowledges that there are a variety of pathways to recovery
Slide16Slide17Slide18Sarah Rider
Psychiatric Nurse Practitioner
sarah.rider@cuanschutz.edu720.848.3037 (CeDAR outpatient)
720.848.3000 (CeDAR main)
Slide19References
American Association of Diabetes Educators (2017). Speaking the language of diabetes. Retrieved from https://www.diabeteseducator.org/practice/educator-tools/app-resources/diabetes-language-paper American Psychological Association. Guidelines for
nonhandicapping language in APA journals (n.d.). Retrieved from http://www.apastyle.org/manual/related/nonhandicapping- language.aspx. American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, D.C. Ashford, R. D., Brown, A. M., & Curtis, B. (2018). Substance use, recovery, and linguistics: The impact of word choice on explicit and implicit bias. Drug and Alcohol Dependence, 189, 131-138. doi:10.1016/j.drugalcdep.2018.05.005 Ashford, R. D., Brown, A. M., & Curtis, B. (2018). Systemic barriers in substance use disorder treatment: A prospective qualitative study of professionals in the field. Drug and Alcohol Dependence, 189, 62-69. doi:10.1016/j.drugalcdep.2018.04.033 Broyles, L. M., Binswanger, I. A., Jenkins, J. A., Finnell
, D. S., Faseru, B., Cavaiola
, A., . . . Gordon, A. J. (2014). Confronting Inadvertent Stigma and Pejorative Language in Addiction Scholarship: A Recognition and Response.
Substance Abuse, 35
(3), 217-221. doi:10.1080/08897077.2014.930372
Cortina, S. C. (2013). Stigmatizing Harm Reduction Through Language.
Journal of Addictions Nursing, 24
(2), 102-107. doi:10.1097/jan.0b013e3182929466
Dickinson, J. K., Guzman, S. J.,
Maryniuk
, M. D., O’Brian, C. A., Kadohiro, J. K., Jackson, R. A., . . . Funnell, M. M. (2017). The Use of Language in Diabetes Care and Education. The Diabetes Educator, 43
(6), 551-564. doi:10.1177/0145721717735535 Friedmann, P. D., & Schwartz, R. P. (2012). Just call it “treatment”. Addiction Science & Clinical Practice, 7(1). doi:10.1186/1940-0640-7-10 Goodyear, K., Haass-Koffler, C. L., & Chavanne, D. (2018). Opioid use and stigma: The role of gender, language and precipitating events. Drug and Alcohol Dependence, 185, 339-346. doi:10.1016/j.drugalcdep.2017.12.037 Kelly, J. F., Spallin, E.R. (2016). Toward an addiction-ary: language, stigma, treatment, and policy. National Association of Drug Court Professionals, Anaheim, CA Kelly, J. F., & Westerhoff
, C. M. (2010). Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. International Journal of Drug Policy, 21(3), 202-207. doi:10.1016/j.drugpo.2009.10.010
Kelly, J. F.,
Wakeman
, S. E., &
Saitz
, R. (2015). Stop Talking ‘Dirty’: Clinicians, Language, and Quality of Care for the Leading Cause of Preventable Death in the United States.
The American Journal of Medicine, 128
(1), 8-9. doi:10.1016/j.amjmed.2014.07.043
Slide21Matthews, S., Dwyer, R., & Snoek, A. (2017). Stigma and Self-Stigma in Addiction.
Journal of Bioethical Inquiry, 14(2), 275-286. doi:10.1007/s11673-017-9784-y
National Academies of Sciences, Engineering, and Medicine (2016). Ending discrimination against people with mental and substance use disorders: the evidence for stigma change. The National Academies Press. doi.org/10.17226/23442.
Olsen, Y., & Sharfstein, J. M. (2014). Confronting the Stigma of Opioid Use Disorder—and Its Treatment. Jama, 311(14), 1393. doi:10.1001/jama.2014.2147 Office of National Drug Control Policy (2017). Changing the Language of Addiction. Retrieved from https://obamawhitehouse.archives.gov/blog/2017/01/13/changing-language-addiction Radcliffe, P., & Stevens, A. (2008). Are drug treatment services only for ‘thieving junkie scumbags’? Drug users and the management of stigmatised identities. Social Science & Medicine, 67(7), 1065-1073. doi:10.1016/j.socscimed.2008.06.004 Scholten, W., Simon, O., Maremmani, I., Wells, C., Kelly, J., Hämmig, R., & Radbruch
, L. (2017). Access to treatment with controlled medicines rationale and recommendations for neutral, precise, and respectful language. Public Health, 153, 147-153. doi:10.1016/j.puhe.2017.08.021
Worley, J., & Delaney, K. R. (2017). “Turning the tide” in Treatment of substance use: A nursing response.
Journal of Nursing Education and Practice, 8
(2), 116. doi:10.5430/jnep.v8n2p116
Slide22